[1]
Ghafouri-Fard S, Shirvani-Farsani Z, Branicki W, Taheri M. MicroRNA signature in renal cell carcinoma. Front Oncol 2020; 10: 596359.
[http://dx.doi.org/10.3389/fonc.2020.596359] [PMID: 33330087]
[http://dx.doi.org/10.3389/fonc.2020.596359] [PMID: 33330087]
[2]
Mytsyk Y, Dosenko V, Skrzypczyk MA, et al. Potential clinical applications of microRNAs as biomarkers for renal cell carcinoma. Cent European J Urol 2018; 71(3): 295-303.
[PMID: 30386650]
[PMID: 30386650]
[3]
Dorff TB, Goldkorn A, Quinn DI. Review: Targeted therapy in renal cancer. Ther Adv Med Oncol 2009; 1(3): 183-205.
[http://dx.doi.org/10.1177/1758834009349119] [PMID: 21789121]
[http://dx.doi.org/10.1177/1758834009349119] [PMID: 21789121]
[4]
Li M, Wang Y, Song Y, et al. MicroRNAs in renal cell carcinoma: A systematic review of clinical implications. Oncol Rep 2015; 33(4): 1571-8.
[http://dx.doi.org/10.3892/or.2015.3799] [PMID: 25682771]
[http://dx.doi.org/10.3892/or.2015.3799] [PMID: 25682771]
[5]
Yang L, Zou X, Zou J, Zhang G. Review of recent research on the role of MicroRNAs in renal cancer. Med Sci Monit 2021; 27: e930639-1 -
e930639-17.
[http://dx.doi.org/10.12659/MSM.930639]
[http://dx.doi.org/10.12659/MSM.930639]
[6]
Sellitti D, Doi S. MicroRNAs in renal cell carcinoma. MicroRNA 2015; 4(1): 26-35.
[http://dx.doi.org/10.2174/2211536604666150713105247] [PMID: 26165467]
[http://dx.doi.org/10.2174/2211536604666150713105247] [PMID: 26165467]
[7]
Al-Ali BM, Ress AL, Gerger A, Pichler M. MicroRNAs in renal cell carcinoma: Implications for pathogenesis, diagnosis, prognosis and therapy. Anticancer Res 2012; 32(9): 3727-32.
[PMID: 22993312]
[PMID: 22993312]
[8]
Chen B, Duan L, Yin G, Tan J, Jiang X. Simultaneously expressed miR-424 and miR-381 synergistically suppress the proliferation and survival of renal cancer cells-Cdc2 activity is up-regulated by targeting WEE1. Clinics 2013; 68(6): 825-33.
[http://dx.doi.org/10.6061/clinics/2013(06)17] [PMID: 23778472]
[http://dx.doi.org/10.6061/clinics/2013(06)17] [PMID: 23778472]
[9]
Wulfken LM, Moritz R, Ohlmann C, et al. MicroRNAs in renal cell carcinoma: Diagnostic implications of serum miR-1233 levels. PLoS One 2011; 6(9): e25787.
[http://dx.doi.org/10.1371/journal.pone.0025787] [PMID: 21984948]
[http://dx.doi.org/10.1371/journal.pone.0025787] [PMID: 21984948]
[10]
Zhai Q, Zhou L, Zhao C, et al. Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma. Biochem Biophys Res Commun 2012; 419(4): 621-6.
[http://dx.doi.org/10.1016/j.bbrc.2012.02.060] [PMID: 22369946]
[http://dx.doi.org/10.1016/j.bbrc.2012.02.060] [PMID: 22369946]
[11]
Iwamoto H, Kanda Y, Sejima T, Osaki M, Okada F, Takenaka A. Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma. Int J Oncol 2014; 44(1): 53-8.
[http://dx.doi.org/10.3892/ijo.2013.2169] [PMID: 24212760]
[http://dx.doi.org/10.3892/ijo.2013.2169] [PMID: 24212760]
[12]
Zhao A, Li G, Péoc’h M, Genin C, Gigante M. Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma. Exp Mol Pathol 2013; 94(1): 115-20.
[http://dx.doi.org/10.1016/j.yexmp.2012.10.005] [PMID: 23064048]
[http://dx.doi.org/10.1016/j.yexmp.2012.10.005] [PMID: 23064048]
[13]
Teixeira AL, Ferreira M, Silva J, et al. Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients. Tumour Biol 2014; 35(5): 4057-66.
[http://dx.doi.org/10.1007/s13277-013-1531-3] [PMID: 24379138]
[http://dx.doi.org/10.1007/s13277-013-1531-3] [PMID: 24379138]
[14]
Renner AM, Derichsweiler C, Ilyas S, Gessner I, Fries JWU, Mathur S. High efficiency capture of biomarker miRNA15a for noninvasive diagnosis of malignant kidney tumors. Biomater Sci 2022; 10(4): 1113-22.
[http://dx.doi.org/10.1039/D1BM01737C] [PMID: 35048092]
[http://dx.doi.org/10.1039/D1BM01737C] [PMID: 35048092]
[15]
Cerqueira DM, Tayeb M, Ho J. MicroRNAs in kidney development and disease. JCI Insight 2022; 7(9): e158277.
[http://dx.doi.org/10.1172/jci.insight.158277] [PMID: 35531954]
[http://dx.doi.org/10.1172/jci.insight.158277] [PMID: 35531954]
[16]
Swearson S, Rataan AO, Eliason S, et al. MicroRNA expression in clear cell renal cell carcinoma cell lines and tumor biopsies: Potential therapeutic targets. Int J Mol Sci 2022; 23(10): 5604.
[http://dx.doi.org/10.3390/ijms23105604] [PMID: 35628416]
[http://dx.doi.org/10.3390/ijms23105604] [PMID: 35628416]
[17]
Lichner Z, Mejia-Guerrero S, Ignacak M, et al. Pleiotropic action of renal cell carcinoma-dysregulated miRNAs on hypoxia-related signaling pathways. Am J Pathol 2012; 180(4): 1675-87.
[http://dx.doi.org/10.1016/j.ajpath.2011.12.030] [PMID: 22326755]
[http://dx.doi.org/10.1016/j.ajpath.2011.12.030] [PMID: 22326755]
